Education
About Us
Working with TipRanks
Follow Us
MEI Pharma (MEIP)
NASDAQ:MEIP
Total Valuation
MEI Pharma has a market cap or net worth of $41.31M. The enterprise value is -$17.02K.
Market Cap$41.31M
Enterprise Value-$17.02K
Share Statistics
MEI Pharma has 6,662,857 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,662,857
Owned by Insiders1.20%
Owned by Institutions26.03%
Financial Efficiency
MEI Pharma’s return on equity (ROE) is 0.54 and return on invested capital (ROIC) is 44.04%.
Return on Equity (ROE)0.54
Return on Assets (ROA)0.43
Return on Invested Capital (ROIC)44.04%
Return on Capital Employed (ROCE)0.44
Revenue Per Employee2.33M
Profits Per Employee634.93K
Employee Count28
Asset Turnover1.58
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.03
Price to Fair Value0.58
Price to FCF-0.55
Price to Operating Cash Flow-0.55
PEG Ratio-0.04
Income Statement
In the last 12 months, MEI Pharma had revenue of 65.30M and earned 17.78M in profits. Earnings per share was 2.67.
Revenue65.30M
Gross Profit64.91M
Operating Income14.54M
Pretax Income17.78M
Net Income17.78M
EBITDA26.38M
Earnings Per Share (EPS)2.67
Cash Flow
In the last 12 months, operating cash flow was -36.38M and capital expenditures 0.00, giving a free cash flow of -36.38M billion.
Operating Cash Flow-36.38M
Free Cash Flow-36.38M
Free Cash Flow per Share-5.46
Dividends & Yields
MEI Pharma pays an annual dividend of $1.75, resulting in a dividend yield of ―
Dividend Per Share$1.75
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change85.39%
50-Day Moving Average2.74
200-Day Moving Average2.61
Relative Strength Index (RSI)79.76
Average Volume (3m)1.77M
Important Dates
MEI Pharma upcoming earnings date is Aug 28, 2025, After Close (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend DateNov 16, 2023
Financial Position
MEI Pharma as a current ratio of 4.88, with Debt / Equity ratio of 0.00%
Current Ratio4.88
Quick Ratio4.88
Debt to Market Cap0.00
Net Debt to EBITDA-0.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MEI Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MEI Pharma EV to EBITDA ratio is 0.58, with an EV/FCF ratio of -0.30.
EV to Sales0.23
EV to EBITDA0.58
EV to Free Cash Flow-0.30
EV to Operating Cash Flow-0.30
Balance Sheet
MEI Pharma has $20.47M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$20.47M billion.
Cash & Marketable Securities$20.47M
Total Debt$0.00
Net Cash-$20.47M
Net Cash Per Share-$3.07
Tangible Book Value Per Share$4.96
Margins
Gross margin is 0.00%, with operating margin of 22.27%, and net profit margin of 27.23%.
Gross Margin0.00%
Operating Margin22.27%
Pretax Margin27.23%
Net Profit Margin27.23%
EBITDA Margin40.40%
EBIT Margin38.96%
Analyst Forecast
The average price target for MEI Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast-292.59%